Showing 1 - 10 results of 10 for search 'Stephen H. Zinner', query time: 0.04s Refine Results
  1. 1
    Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets?

    Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets? by Glenn S. Tillotson, Stephen H. Zinner

    Published 2015-07-01
    Get full text
    Article
  2. 2
    In Vitro Dynamic Model Evaluation of Meropenem Alone and in Combination with Avibactam Against Carbapenemase-Producing <i>Klebsiella pneumoniae</i>

    In Vitro Dynamic Model Evaluation of Meropenem Alone and in Combination with Avibactam Against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> by Elena N. Strukova, Yury A. Portnoy, Maria V. Golikova, Stephen H. Zinner

    Published 2024-12-01
    Get full text
    Article
  3. 3
    Fluorescence Microscopy: Determination of Meropenem Activity against <i>Klebsiella pneumoniae</i>

    Fluorescence Microscopy: Determination of Meropenem Activity against <i>Klebsiella pneumoniae</i> by Kamilla N. Alieva, Maria V. Golikova, Anastasia A. Kuznetsova, Stephen H. Zinner

    Published 2023-07-01
    Get full text
    Article
  4. 4
    Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> and the Inoculum Effect

    Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing <i>Klebsiella p... by Elena N. Strukova, Maria V. Golikova, Svetlana A. Dovzhenko, Mikhail B. Kobrin, Stephen H. Zinner

    Published 2023-12-01
    Get full text
    Article
  5. 5
    MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>

    MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i> by Maria V. Golikova, Elena N. Strukova, Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>

    Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i> by Maria V. Golikova, Elena N. Strukova, Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov

    Published 2020-08-01
    Get full text
    Article
  7. 7
    Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination

    Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditiona... by Alla V. Filimonova, Maria V. Golikova, Elena N. Strukova, Yury A. Portnoy, Anastasiya A. Kuznetsova, Stephen H. Zinner

    Published 2021-12-01
    Get full text
    Article
  8. 8
    Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>

    Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Produc... by Maria V. Golikova, Elena N. Strukova, Kamilla N. Alieva, Vladimir A. Ageevets, Alisa A. Avdeeva, Ofeliia S. Sulian, Stephen H. Zinner

    Published 2023-05-01
    Get full text
    Article
  9. 9
    Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model

    Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharma... by Maria V. Golikova, Kamilla N. Alieva, Elena N. Strukova, Daria A. Kondratieva, Nika F. Petrova, Mayya A. Petrova, Stephen H. Zinner

    Published 2023-12-01
    Get full text
    Article
  10. 10
    <i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio

    <i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio by Maria V. Golikova, Kamilla N. Alieva, Alla V. Filimonova, Vladimir A. Ageevets, Ofeliia S. Sulian, Alisa A. Avdeeva, Sergey V. Sidorenko, Stephen H. Zinner

    Published 2022-06-01
    Get full text
    Article

Search Tools: